These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Diet, drugs, devices, and surgery for weight management. Med Lett Drugs Ther; 2018 Jun; 60(1548):91-98. PubMed ID: 29913463 [No Abstract] [Full Text] [Related]
5. Medications for weight loss. Mordes JP; Liu C; Xu S Curr Opin Endocrinol Diabetes Obes; 2015 Apr; 22(2):91-7. PubMed ID: 25692921 [TBL] [Abstract][Full Text] [Related]
7. Obesity: Scope, Lifestyle Interventions, and Medical Management. McCafferty BJ; Hill JO; Gunn AJ Tech Vasc Interv Radiol; 2020 Mar; 23(1):100653. PubMed ID: 32192633 [TBL] [Abstract][Full Text] [Related]
8. Reducing the risk of obesity: defining the role of weight loss drugs. Ling H; Lenz TL; Burns TL; Hilleman DE Pharmacotherapy; 2013 Dec; 33(12):1308-21. PubMed ID: 23712541 [TBL] [Abstract][Full Text] [Related]
9. An Introduction to Current State of Obesity Interventions: A Guide for the Interventional Radiologist. Weiss CR Tech Vasc Interv Radiol; 2020 Mar; 23(1):100652. PubMed ID: 32192632 [No Abstract] [Full Text] [Related]
10. Obesity: The New Global Epidemic Pharmacological Treatment, Opportunities and Limits for Personalized Therapy. Milano W; De Biasio V; Di Munzio W; Foggia G; Capasso A Endocr Metab Immune Disord Drug Targets; 2020; 20(8):1232-1243. PubMed ID: 32410565 [TBL] [Abstract][Full Text] [Related]
11. Past, present and future of pharmacotherapy for obesity. Benaiges D; Pedro-Botet J; Flores-Le Roux JA; Climent E; Goday A Clin Investig Arterioscler; 2017; 29(6):256-264. PubMed ID: 28935287 [TBL] [Abstract][Full Text] [Related]
13. New obesity agents: lorcaserin and phentermine/topiramate. Fleming JW; McClendon KS; Riche DM Ann Pharmacother; 2013; 47(7-8):1007-16. PubMed ID: 23800750 [TBL] [Abstract][Full Text] [Related]
14. Answers to Clinical Questions in the Primary Care Management of People with Obesity: Pharmacologic Management. Fujioka K; Braverman-Panza J J Fam Pract; 2016 Jul; 65(7 Suppl):S16-23. PubMed ID: 27565106 [TBL] [Abstract][Full Text] [Related]
15. Pharmacotherapy of obesity: Available medications and drugs under investigation. Pilitsi E; Farr OM; Polyzos SA; Perakakis N; Nolen-Doerr E; Papathanasiou AE; Mantzoros CS Metabolism; 2019 Mar; 92():170-192. PubMed ID: 30391259 [TBL] [Abstract][Full Text] [Related]
16. Combination Therapies for Obesity. Camilleri M; Acosta A Metab Syndr Relat Disord; 2018 Oct; 16(8):390-394. PubMed ID: 29993319 [TBL] [Abstract][Full Text] [Related]
17. Current and emerging pharmacotherapies for obesity in Australia. Hocking S; Dear A; Cowley MA Obes Res Clin Pract; 2017; 11(5):501-521. PubMed ID: 28818558 [TBL] [Abstract][Full Text] [Related]